Medicure Inc.
MPH.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -8.82% | -10.81% | -7.06% | -9.26% | -7.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.82% | -10.81% | -7.06% | -9.26% | -7.92% |
| Cost of Revenue | 33.35% | 18.40% | 9.25% | 6.16% | -18.54% |
| Gross Profit | -27.17% | -23.35% | -14.41% | -15.97% | -2.38% |
| SG&A Expenses | 2.91% | 4.35% | 2.96% | -1.18% | -6.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.80% | 10.62% | 2.56% | -0.68% | -8.75% |
| Operating Income | -447.45% | -244.63% | -270.31% | -168.68% | 10.80% |
| Income Before Tax | -270.22% | -213.04% | -194.96% | -162.27% | -62.01% |
| Income Tax Expenses | 98.29% | 25.88% | 420.00% | 15.15% | 352.52% |
| Earnings from Continuing Operations | -286.40% | -221.16% | -197.95% | -165.10% | -63.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -286.40% | -221.16% | -197.95% | -165.10% | -63.84% |
| EBIT | -447.45% | -244.63% | -270.31% | -168.68% | 10.80% |
| EBITDA | -177.21% | -127.29% | -82.45% | -64.10% | 3.21% |
| EPS Basic | -284.50% | -219.40% | -196.45% | -163.75% | -64.12% |
| Normalized Basic EPS | -469.28% | -247.61% | -269.72% | -181.42% | -18.90% |
| EPS Diluted | -302.09% | -225.49% | -203.05% | -168.46% | -66.67% |
| Normalized Diluted EPS | -475.47% | -249.94% | -275.71% | -184.76% | -18.88% |
| Average Basic Shares Outstanding | 0.78% | 1.24% | 1.69% | 1.46% | 1.01% |
| Average Diluted Shares Outstanding | -2.98% | 3.07% | 3.83% | 3.68% | 4.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
